Study Assesses Unmet Needs of Cancer Caregivers
the Cancer Therapy Advisor take:
Caregivers report the highest percentage of unmet needs for support in areas regarding fear concerning the patient’s condition, receiving disease-related information, and emotional support for themselves, according to an article published online in Cancer.
A total of 188 dyads of patients diagnosed with lung, urological, or gastrointestinal cancer and their primary caregivers took part in the study’s cross-sectional survey.
Caregivers completed the Supportive Care Needs Survey self-report questionnaire and the patients completed the corresponding questionnaire.
In the questionnaires, both the caregivers and the patients supplied information describing their distress, anxiety, and depression. Medical records provided clinical characteristics of the patients.
The majority (72.3%) of the caregivers was female and their median age was 57.8 years.
Results showed that caregivers were more distressed (P<0.01) and had greater anxiety (P<0.01) scores than the patients.
Furthermore, more caregivers reported having at least 10 unmet needs than no unmet needs (43.6% vs 14.4%, respectively). Unmet needs reported by patients and caregivers’ anxiety predicted unmet needs of caregivers, to some extent.
The study suggests caregivers undergo systematic assessments to examine their unmet needs and determine specific offers for the caregivers.
Caregivers report the highest percentage of unmet needs for support in areas regarding fear concerning the patient’s condition.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Long-term Survival From Ipilimumab/Nivolumab Combination in Metastatic Melanoma
- Questions Remain for First-line Treatment Selection and Sequencing in Advanced Melanoma
- Repeat T790M Testing Recommended for TKI-resistant Patients With NSCLC
- Ginkgo Biloba and Cancer
- Initial Therapy at Academic Centers Linked to Prolonged Overall Survival in NSCLC
- Affordable Care Act Linked to Lower Rates of Cancer Diagnosis Among Uninsured
- FDA Approves Axicabtagene Ciloleucel for Non-Hodgkin Lymphoma, Questions Remain About Cost and Toxicity
- PAK Inhibition Could Abrogate MAPK Inhibitor Resistance in BRAF-mutant Melanoma
- Lung Cancer Treatment in North America: Recent Advances and Future Promises
- Atezolizumab Maintains Clinical Benefit After 2 Years in Advanced NSCLC